Jenkins S - Search Results

1

Applying mathematical modelling to estimate the impact of COVID-19-related VMMC service disruptions on new HIV infections in Zimbabwe.

Chagoma N, Kanyenda T, Pindiwe B, Nyika H, Nyazema L, Stover J, Resar D, Shoko N, Jenkins S, Katanda Y, Xaba S, Mugurungi O. Chagoma N, et al. Among authors: jenkins s. BMC Infect Dis. 2023 Feb 23;23(1):113. doi: 10.1186/s12879-023-08081-7. BMC Infect Dis. 2023. PMID: 36823550 Free PMC article.

2

The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.

Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G. Jamieson L, et al. Among authors: jenkins s. AIDS. 2020 May 1;34(6):883-891. doi: 10.1097/QAD.0000000000002486. AIDS. 2020. PMID: 32004205

3

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.

Smith J, Bansi-Matharu L, Cambiano V, Dimitrov D, Bershteyn A, van de Vijver D, Kripke K, Revill P, Boily MC, Meyer-Rath G, Taramusi I, Lundgren JD, van Oosterhout JJ, Kuritzkes D, Schaefer R, Siedner MJ, Schapiro J, Delany-Moretlwe S, Landovitz RJ, Flexner C, Jordan M, Venter F, Radebe M, Ripin D, Jenkins S, Resar D, Amole C, Shahmanesh M, Gupta RK, Raizes E, Johnson C, Inzaule S, Shafer R, Warren M, Stansfield S, Paredes R, Phillips AN; HIV Modelling Consortium. Smith J, et al. Among authors: jenkins s. Lancet HIV. 2023 Apr;10(4):e254-e265. doi: 10.1016/S2352-3018(22)00365-4. Epub 2023 Jan 12. Lancet HIV. 2023. PMID: 36642087 Free PMC article.

4

Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.

Milali MP, Resar D, Kaftan D, Campbell J, Olowu A, Edwards D, Platais I, Kim HY, Jenkins S, Bershteyn A. Milali MP, et al. Among authors: jenkins s. Front Reprod Health. 2023 May 17;5:1144217. doi: 10.3389/frph.2023.1144217. eCollection 2023. Front Reprod Health. 2023. PMID: 37266447 Free PMC article.

5

Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low- and middle-income countries.

Jenkins SY, Resar D, Panos Z, Staple A, Watkins M, Ripin D, Amole C. Jenkins SY, et al. J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26101. doi: 10.1002/jia2.26101. J Int AIDS Soc. 2023. PMID: 37439082 Free PMC article.

6

Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: a mathematical modelling study.

Chevalier JM, Hansen MA, Coskun E, Sy KTL, Drakes J, Dowling S, Williams A, Jenkins S, Amole C, Haimbe P, Mpasela F, Shakwelele H, Nichols BE. Chevalier JM, et al. Among authors: jenkins s. Lancet Glob Health. 2024 Mar;12(3):e457-e466. doi: 10.1016/S2214-109X(23)00588-0. Lancet Glob Health. 2024. PMID: 38365416 Free article.

7

Tackling HIV by empowering adolescent girls and young women: a multisectoral, government led campaign in South Africa.

Subedar H, Barnett S, Chaka T, Dladla S, Hagerman E, Jenkins S, Matshimane G, Mangold K, Msimanga B, Pooe R, Schultz L, Pillay Y. Subedar H, et al. Among authors: jenkins s. BMJ. 2018 Dec 7;363:k4585. doi: 10.1136/bmj.k4585. BMJ. 2018. PMID: 30530572 Free PMC article.

8

Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.

Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, Jenkins S, Subedar H, Hoke T, Mullick S. Pillay D, et al. Among authors: jenkins s. PLoS One. 2020 Apr 30;15(4):e0228620. doi: 10.1371/journal.pone.0228620. eCollection 2020. PLoS One. 2020. PMID: 32352969 Free PMC article.

9

Investigating Internalization of Reporter-Protein-Functionalized Polyhedrin Particles by Brain Immune Cells.

Parwana KAK, Kaur Gill P, Njanike R, Yiu HHP, Adams CF, Chari DM, Jenkins SI. Parwana KAK, et al. Among authors: jenkins si. Materials (Basel). 2024 May 14;17(10):2330. doi: 10.3390/ma17102330. Materials (Basel). 2024. PMID: 38793398 Free PMC article.

10

WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma.

Van Treeck BJ, Olave MC, Watkins RD, Lu H, Moreira RK, Mounajjed T, Johnson MJ, Smith CY, Ilyas SI, Tran NH, Jenkins SM, Reed KA, Smoot R, Mahipal A, Allende D, Graham RP. Van Treeck BJ, et al. Among authors: jenkins sm. HPB (Oxford). 2024 Apr 24:S1365-182X(24)01277-2. doi: 10.1016/j.hpb.2024.04.011. Online ahead of print. HPB (Oxford). 2024. PMID: 38789383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,996 results

Search Page